Rishikesh
Rishikesh Maktedar, Tampere FI
Patent application number | Description | Published |
---|---|---|
20110145749 | METHOD AND APPARATUS FOR USER INTERFACE DISPLAYS - An approach for providing a user interface display, for example, with a first window that includes a first predefined area to present a status display control and a second predefined area that is separately defined in the first window to present a status display related to the status display control. Further providing, for example, the user interface display with a second window that includes the first predefined area to present the status display control and a third area that transparently presents the status display over content in the second window upon selection of the status display control. | 06-16-2011 |
Rishikesh Mankidy, Saskatoon CA
Patent application number | Description | Published |
---|---|---|
20120035250 | PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING - Described herein are routes of synthesis and therapeutic uses of 1-alkyl, 2-acyl glycerol derivatives of formula I: which when administered to mammalian biological systems result in increased cellular concentrations of specific sn-2 substituted ethanolamine plasmalogens independent of the ether lipid synthesis capacity of the system. Elevating levels of the specific sn-2 substituted species in this way can cause lowering of membrane cholesterol levels and the lowering of amyloid secretion. These compounds can be used for the treatment or prevention of diseases of aging associated with increased membrane cholesterol, increased amyloid, and decreased plasmalogen levels, such as neurodegeneration (including Alzheimer's disease, Parkinson's disease and age-related macular degeneration), cognitive impairment, dementia, cancer (e.g. prostate, lung, breast, ovarian, and kidney cancers), osteoporosis, bipolar disorder and vascular diseases (such as atherosclerosis, hypercholesterolemia). | 02-09-2012 |
20130116312 | PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING - Described herein are routes of synthesis and therapeutic uses of 1-alkyl, 2-acyl glycerol derivatives of formula I: which when administered to mammalian biological systems result in increased cellular concentrations of specific sn-2 substituted ethanolamine plasmalogens independent of the ether lipid synthesis capacity of the system. Elevating levels of the specific sn-2 substituted species in this way can cause lowering of membrane cholesterol levels and the lowering of amyloid secretion. These compounds can be used for the treatment or prevention of diseases of aging associated with increased membrane cholesterol, increased amyloid, and decreased plasmalogen levels, such as neurodegeneration (including Alzheimer's disease, Parkinson's disease and age-related macular degeneration), cognitive impairment, dementia, cancer (e.g. prostate, lung, breast, ovarian, and kidney cancers), osteoporosis, bipolar disorder and vascular diseases (such as atherosclerosis, hypercholesterolemia). | 05-09-2013 |
Rishikesh Tembe, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20120124057 | EXTERNAL USER IDENTIFICATION AND VERIFICATION USING REPUTATION DATA - In a system and method for user identification and verification using reputation data, a processor-implemented feedback component receives feedback data pertaining to a user of a network-based community in response to a transaction in which the user is a party. A processor-implemented tracking component tracks transaction data and metadata associated with the transaction data and the feedback data. A processor-implemented aggregation component aggregates the received feedback data and the tracked data and metadata to yield an aggregated set of data pertaining to the user. A processor-implemented reputation component generates a reputation value for the user from the aggregated set of data. If the reputation value is greater than a predetermined threshold value, the user is considered trustworthy, and if the reputation value is not greater than the predetermined threshold value, the user is not considered trustworthy. | 05-17-2012 |
20120124192 | USING BEHAVIORAL DATA IN RATING USER REPUTATION - In a system and method for using user behavior and interaction data to rate a reputation of a user, a processor-implemented tracking component tracks an interaction of a user with a network-based publisher. A processor-implemented reputation component generates a reputation value for the user from the tracked user interaction. | 05-17-2012 |